SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
April 21, 2016
Date of Report
(Date of Earliest Event Reported)
SELLA CARE, INC.
(Exact Name of Registrant as Specified in its Charter)
WESTERN RIDGE ACQUISITION CORPORATION
(Former Name of Registrant as Specified in its Charter)
Delaware 000-55478 47-4161980
(State or other (Commission File Number) (IRS Employer
jurisdiction Identification No.)
of incorporation)
621 S. Virgil Avenue #470
Los Angeles, California 90005
(Address of principal executive offices) (zip code)
213-219-7746
(Registrant's telephone number, including area code)
215 Apolena Avenue
Newport Beach, California 92662
(Former Address of Principal Executive Offices)
ITEM 3.02 Unregistered Sales of Equity Securities
On April 22, 2016 Sella Care, Inc. (formerly Western Ridge
Acquisition Corporation) (the "Registrant" or the "Company") issued
5,000,000 shares of its common stock pursuant to Section 4(2) of the
Securities Act of 1933 at par representing 94% of the total outstanding
5,500,000 shares of common stock as follows:
5,000,000 Ho Soon Hwang Yang
With the issuance of the stock and the redemption of 19,500,000 shares
of stock (discussed below), the Company effected a change in its control and
the new majority shareholder(s) elected new management of the Company. The
Company may develop its business plan by future acquisitions or mergers but
no agreements have been reached regarding any acquisition or other business
combination. The Company changed its name as part of the change in control.
If the Company makes any acquisitions, mergers or other business combination,
the Company will file a Form 8-K but until such time the Company remains a
shell company.
ITEM 5.01 Changes in Control of Registrant
On April 21, 2016, the following events occurred which resulted in a
change of control of the Registrant:
1. The Registrant redeemed an aggregate of 19,500,000 of the then
20,000,000 shares of outstanding stock at a redemption price of $.0001 per
share for an aggregate redemption price of $1,950.
2. The then current officers and directors resigned.
3. New officer(s) and director(s) were appointed and elected.
The disclosure required by Item 5.01(a)(8) of Form 8-K was previously
filed with the Securities and Exchange Commission on Form 10-12G filed on
July 28, 2015 as amended and supplemented by the information contained in
this report.
The Registrant anticipates that it will effect a merger with a private
company to develop operations and a business plan.
ITEM 5.02 Departure of Directors or Principal Officers;
Election of Directors
On April 21, 2016 the following events occurred:
James M. Cassidy resigned as the Registrant's president, secretary
and director.
James McKillop resigned as the Registrant's vice president and
director.
Jun Ho Yang was named director of the Registrant.
Jun Ho Yang was appointed Chief Executive Officer, Secretary and
Treasurer of the Registrant.
Jun Ho Yang serves as the sole director and officer of the Registrant.
From 2011 to the present, Mr. Yang has served as Vice President of Sella Care,
Inc., a private company located in Los Angeles, California which sells and
distributes vitamins, mineral supplements and other innovative health care
products. The company is dedicated to improving and promoting vibrant health
and lifestyle. In that position, Mr. Yang has managed domestic and overseas
sales and marketing and financial matters. Mr. Yang is actively involved in
non-profit work in the community including the purchase of a non-profit
newspaper publication (Christian Herald) and a cable television (CHTZ 18.88).
Mr. Yang currently serves as chairman of the board for both entities.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunder duly authorized.
SELLA CARE, INC.
Date: April 22, 2016 /s/ Jun Ho Yang
Chief Executive Officer